Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > I don't know what it takes

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Apr 17, 2024 11:10am

98 Views

Post# 35993759

RE:RE:RE:RE:RE:RE:RE:I don't know what it takes

Someone I know asked the company if Soleus nominated him and was told that THTX found him on their own. So, it is second hand info, but reliable info if THTX is telling the truth (in other words, my source is almost certainly accurately reporting what THTX told him).

Also, Soleus did file with the SEC as an activist shareholder indicating a potential interest in influencing the company through their activism. Now, I will believe Soleus would actually act in an activist manner when I see it since they invest in a lot of small companies and likely do not want a reputation as an activist investor. There is nothing in the public arena which suggests they have taken any action yet which comports with their potential activism.

So, my best guess is they vote in favor of management at the AGM, even if they are not happy with them (and how could they be happy with them as they have suffered similar losses as the rest of us). It is just not typical for institutional investors to vote against management unless their fund was expressly organized for that purpose.

Still, Soleus did file to be an activist with the SEC, so there is clearly some chance they may be looking to do something. I believe someone here pointed out that the new large shareholder might be friends of Soleus and may have had a more activist approach? So, maybe something is up, but as I said, I will beleive it whenI see it. And if they are planning on doing something at the AGM, they need to reveal themselves as having such intentions very soon.

palinc2000 wrote:
Why do you have that impression?

Soleus is not known as an Activist shareholder and this is probably the reason that Zwick 's nomination was not announced as a Soleus nominee even though I think he was nominated as a result of discussions between Thtx and Soleus...and Soleus may have signed an NDA

SPCEO1 wrote: I am under the impression Zwick was not recommended by Soleus.
Trogarzon wrote: Hope they fly out the door... all of them except Zwick. Then Soleus can monetise.